tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MNMD Stock Latest News

Psychedelic: Needham initiates coverage of atai, GH Research, MindMed
The FlyPsychedelic: Needham initiates coverage of atai, GH Research, MindMed
6d ago
ABBV
ATAI
MindMed Issues Inducement Grant to New Employee
PremiumCompany Announcements
MindMed Issues Inducement Grant to New Employee
6d ago
MNMD
Mind Medicine initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Mind Medicine initiated with an Outperform at LifeSci Capital
8d ago
MNMD
3 Best Stocks to Buy Now, 10/13/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 10/13/2025, According to Top Analysts
9d ago
PR
INR
Mind Medicine’s MM120: Promising Phase 3 Trials and Strategic Growth Potential
PremiumRatings
Mind Medicine’s MM120: Promising Phase 3 Trials and Strategic Growth Potential
9d ago
MNMD
Mind Medicine initiated with a Buy at Needham
PremiumThe FlyMind Medicine initiated with a Buy at Needham
9d ago
MNMD
Psychedelic: Exclusive talk with ibogaine clinic Beond
Premium
The Fly
Psychedelic: Exclusive talk with ibogaine clinic Beond
26d ago
ATAI
CMND
MindMed Study Highlights Urgent Need for Suicide Risk Screening in GAD Patients
Premium
Company Announcements
MindMed Study Highlights Urgent Need for Suicide Risk Screening in GAD Patients
28d ago
MNMD
MindMed Issues Inducement Grants to New Employees
PremiumCompany Announcements
MindMed Issues Inducement Grants to New Employees
28d ago
MNMD
Mind Medicine participates in a conference call with Cantor Fitzgerald
PremiumThe Fly
Mind Medicine participates in a conference call with Cantor Fitzgerald
29d ago
MNMD
Psychedelic: Exclusive talk with biopharma company MindMed
PremiumThe Fly
Psychedelic: Exclusive talk with biopharma company MindMed
1M ago
MNMD
Mind Medicine’s Strategic Focus and Commercial Scalability Drive Buy Rating
PremiumRatings
Mind Medicine’s Strategic Focus and Commercial Scalability Drive Buy Rating
1M ago
MNMD
MindMed to Engage in Key September Investor Conferences
PremiumCompany AnnouncementsMindMed to Engage in Key September Investor Conferences
1M ago
MNMD
MindMed’s MM120 Shows Promise in Treating Generalized Anxiety Disorder
Premium
Company Announcements
MindMed’s MM120 Shows Promise in Treating Generalized Anxiety Disorder
1M ago
MNMD
MindMed Issues Inducement Grants to New Employees
Premium
Company Announcements
MindMed Issues Inducement Grants to New Employees
1M ago
MNMD
MindMed Issues Inducement Grants to New Employees
PremiumCompany Announcements
MindMed Issues Inducement Grants to New Employees
1M ago
MNMD
Mind Medicine’s Breakthrough in Anxiety Disorder Treatment
PremiumCompany Announcements
Mind Medicine’s Breakthrough in Anxiety Disorder Treatment
2M ago
8K
MNMD
Mind Medicine announces publication of results from MM120 Phase 2b study
PremiumThe Fly
Mind Medicine announces publication of results from MM120 Phase 2b study
2M ago
MNMD
MindMed Reports Strong Phase 3 Trial Progress and Leadership Appointment
PremiumCompany Announcements
MindMed Reports Strong Phase 3 Trial Progress and Leadership Appointment
3M ago
MNMD
MindMed to Announce Q2 2025 Financial Results in Upcoming Webcast
PremiumCompany AnnouncementsMindMed to Announce Q2 2025 Financial Results in Upcoming Webcast
3M ago
MNMD
Psychedelic: Cybin receives European approval for EMBRACE study
Premium
The Fly
Psychedelic: Cybin receives European approval for EMBRACE study
3M ago
CMND
CMPS
MindMed: Positioned for Success in the Psychedelic Medicine Revolution with Strong Financials and Strategic Advancements
Premium
Ratings
MindMed: Positioned for Success in the Psychedelic Medicine Revolution with Strong Financials and Strategic Advancements
3M ago
MNMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >